heme has been researched along with Cognitive Decline in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bronckaers, A; Foulquier, S; Nelissen, E; Ponsaerts, L; Prickaerts, J; Sandner, P; Schepers, M; Vanmierlo, T | 1 |
| Edmundson, S; Guekht, A; Korczyn, AD; Skoog, I; Zakharov, V | 1 |
| Konovalov, RN; Lagoda, OV; Raskurazhev, AA; Shabalina, AA; Tanashyan, MM | 1 |
| Gavrilova, SI; Kalyn, IaB; Mikhaĭlova, NM; Roshchina, IF; Selezneva, ND | 1 |
1 review(s) available for heme and Cognitive Decline
| Article | Year |
|---|---|
Soluble guanylyl cyclase: A novel target for the treatment of vascular cognitive impairment?
Topics: Cognitive Dysfunction; Cyclic GMP; Heme; Humans; Inflammation; Soluble Guanylyl Cyclase; Vascular Diseases | 2023 |
3 trial(s) available for heme and Cognitive Decline
| Article | Year |
|---|---|
ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment.
Topics: Aged; Aged, 80 and over; Antioxidants; Brain Ischemia; Cognitive Dysfunction; Double-Blind Method; Female; Follow-Up Studies; Heme; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Recurrence; Stroke | 2017 |
Multimodal approach to treatment of neurological complications of chronic brain ischemia.
Topics: Aged; Brain; Brain Ischemia; Central Nervous System Stimulants; Cognitive Dysfunction; Erythrocyte Aggregation; Female; Heme; Hemorheology; Humans; Male; Middle Aged; Nervous System Diseases | 2018 |
[Efficacy of actovegin in the treatment of elderly patients with vascular mild cognitive impairment].
Topics: Aged; Aged, 80 and over; Central Nervous System Stimulants; Cerebrovascular Disorders; Cognition; Cognitive Dysfunction; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heme; Humans; Male; Middle Aged; Neuropsychological Tests; Psychiatric Status Rating Scales; Treatment Outcome | 2013 |